Cointime

Fauna Bio

company

About

Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.

  • 1 - 10

Highlights

Total Funding Amount
$4.32M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Grant
Last Funding Money Raised
$229K
Industries
Biotechnology,Health Care,Hospital,Medical
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$4.32M
Fauna Bio has raised a total of $4.32M in funding over 2 rounds. Their latest funding was raised on Mar 4, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 4, 2021 Grant — 1 National Human Genome Research Institute — Detail
Oct 10, 2019 Grant $229K 1 National Institutes of Health — Detail
Apr 11, 2019 Seed $4.10M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Fauna Bio is funded by 3 investors. National Human Genome Research Institute and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Human Genome Research Institute Yes Grant
National Institutes of Health Yes Grant
Beagle Ventures — Seed
Cointime
เนื้อหา
บริษัท